Teleflex Incorporated (TFX) - Total Assets

Latest as of June 2026: $6.79 Billion USD

Based on the latest financial reports, Teleflex Incorporated (TFX) holds total assets worth $6.79 Billion USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Teleflex Incorporated - Total Assets Trend (1985–2025)

This chart illustrates how Teleflex Incorporated's total assets have evolved over time, based on quarterly financial data. Also see TFX company net worth for the company's overall valuation and market capitalisation.

Teleflex Incorporated - Asset Composition Analysis

Current Asset Composition (December 2025)

Teleflex Incorporated's total assets of $6.79 Billion consist of 27.9% current assets and 72.1% non-current assets. Review TFX liabilities breakdown to assess the company's total debt and financial obligations.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $378.56 Million 5.7%
Accounts Receivable $345.58 Million 5.0%
Inventory $404.39 Million 5.8%
Property, Plant & Equipment $590.10 Million 8.5%
Intangible Assets $1.52 Billion 21.9%
Goodwill $2.31 Billion 33.2%

Asset Composition Trend (1985–2025)

This chart illustrates how Teleflex Incorporated's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See today's stock price for Teleflex Incorporated for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Teleflex Incorporated's current assets represent 27.9% of total assets in 2025, a decrease from 67.4% in 1985.
  • Cash Position: Cash and equivalents constituted 5.7% of total assets in 2025, down from 22.6% in 1985.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 54.0% of total assets, an increase from 0.0% in 1985.
  • Asset Diversification: The largest asset category is goodwill at 33.2% of total assets.

Teleflex Incorporated Competitors by Total Assets

Key competitors of Teleflex Incorporated based on total assets are shown below.

Company Country Total Assets
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
China CN¥12.68 Billion
Andon Health Co Ltd
SHE:002432
China CN¥29.91 Billion
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
China CN¥2.42 Billion
Pegavision
TW:6491
Taiwan NT$16.17 Billion
Nanosonics Ltd
AU:NAN
Australia AU$279.25 Million
Visco Vision Inc.
TW:6782
Taiwan NT$5.82 Billion
QITIAN Technology Group Co Ltd
SHE:300061
China CN¥1.17 Billion
Embecta Corp
NASDAQ:EMBC
USA $1.27 Billion

Teleflex Incorporated - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.60 2.41 2.74
Quick Ratio 2.12 1.44 1.88
Cash Ratio 0.00 0.35 0.86
Working Capital $1.16 Billion $1.01 Billion $979.63 Million

Teleflex Incorporated - Advanced Valuation Insights

This section examines the relationship between Teleflex Incorporated's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.00
Latest Market Cap to Assets Ratio 0.79
Asset Growth Rate (YoY) -2.1%
Total Assets $6.95 Billion
Market Capitalization $5.47 Billion USD

Valuation Analysis

Below Book Valuation: The market values Teleflex Incorporated's assets below their book value (0.79x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Teleflex Incorporated's assets decreased by 2.1% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Teleflex Incorporated (1985–2025)

The table below shows the annual total assets of Teleflex Incorporated from 1985 to 2025.

Year Total Assets Change
2025-12-31 $6.95 Billion -2.12%
2024-12-31 $7.10 Billion -5.77%
2023-12-31 $7.53 Billion +8.73%
2022-12-31 $6.93 Billion +0.82%
2021-12-31 $6.87 Billion -3.93%
2020-12-31 $7.15 Billion +13.36%
2019-12-31 $6.31 Billion +0.51%
2018-12-31 $6.28 Billion +1.56%
2017-12-31 $6.18 Billion +58.86%
2016-12-31 $3.89 Billion +0.33%
2015-12-31 $3.88 Billion -2.48%
2014-12-31 $3.98 Billion -5.51%
2013-12-31 $4.21 Billion +12.56%
2012-12-31 $3.74 Billion -4.70%
2011-12-31 $3.92 Billion +7.71%
2010-12-31 $3.64 Billion -5.10%
2009-12-31 $3.84 Billion -2.23%
2008-12-31 $3.93 Billion -6.24%
2007-12-31 $4.19 Billion +77.53%
2006-12-31 $2.36 Billion -5.88%
2005-12-31 $2.51 Billion -4.86%
2004-12-31 $2.63 Billion +24.82%
2003-12-31 $2.11 Billion +16.39%
2002-12-31 $1.81 Billion +10.91%
2001-12-31 $1.64 Billion +16.68%
2000-12-31 $1.40 Billion +10.91%
1999-12-31 $1.26 Billion +3.91%
1998-12-31 $1.22 Billion +12.67%
1997-12-31 $1.08 Billion +25.80%
1996-12-31 $857.90 Million +9.26%
1995-12-31 $785.20 Million +10.47%
1994-12-31 $710.80 Million +10.96%
1993-12-31 $640.60 Million +19.76%
1992-12-31 $534.90 Million +11.97%
1991-12-31 $477.70 Million +12.37%
1990-12-31 $425.10 Million +15.93%
1989-12-31 $366.70 Million +38.85%
1988-12-31 $264.10 Million +16.91%
1987-12-31 $225.90 Million +21.98%
1986-12-31 $185.20 Million +35.28%
1985-12-31 $136.90 Million --

About Teleflex Incorporated

NYSE:TFX USA Medical Instruments & Supplies
Market Cap
$5.47 Billion
Market Cap Rank
#3352 Global
#1186 in USA
Share Price
$129.02
Change (1 day)
-0.98%
52-Week Range
$100.34 - $142.05
All Time High
$434.21
About

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation an… Read more